MARSHALL WACE, LLP - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,140,843
-69.9%
59,248
-69.1%
0.01%
-70.4%
Q2 2023$13,761,980
+3033.3%
191,511
+2589.4%
0.03%
+2600.0%
Q1 2023$439,223
-58.1%
7,121
-74.0%
0.00%
-50.0%
Q2 2022$1,049,000
-20.7%
27,393
+17.2%
0.00%
-66.7%
Q1 2021$1,323,000
-71.7%
23,374
-70.6%
0.01%
-87.2%
Q1 2020$4,674,00079,4540.05%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,008,508$82,980,00048.53%
Fairmount Funds Management LLC 216,098$17,781,0007.93%
WMS Partners, LLC 250,000$20,570,0004.26%
RTW INVESTMENTS, LP 1,658,316$136,446,0003.84%
MORGAN JESS S & CO INC 39,328$3,236,0003.51%
RA Capital Management 2,035,132$167,451,0003.26%
Ghost Tree Capital, LLC 100,000$8,228,0002.17%
ACUTA CAPITAL PARTNERS, LLC 90,000$7,405,0002.14%
Avidity Partners Management LP 404,900$33,315,0002.14%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,085,836$89,343,0001.97%
View complete list of AXSOME THERAPEUTICS INC shareholders